A Modified Approach for Morbid Obese With Gynecologic Cancer

Gynecologic Cancer: a Modified Approach for Morbid Obese Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03096652

Enrollment

100

Registered

2017-03-30

Start date

2016-08-31

Completion date

2018-12-31

Last updated

2017-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of Cervix, Endometrium and Ovary

Keywords

gynecologic cancer - panniculectomy

Brief summary

Comparing standard midline approach with the modified approach in management of morbid obese patients with gynecologic cancers.

Interventions

PROCEDUREApproach for cancer resection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

1. Resectable (ovarian, endometrial, cervical) cancers. 2. Anaesthetically fit (ASA 1 and 2). 3. Abdominal pannus below symphysis pubis.

Exclusion criteria

1. Non resectable gynecologic cancer. 2. Unfit patients. 3. Patients who refuse to share in the trial.

Design outcomes

Primary

Measure	Time frame	Description
Oncologic outcome	2 weeks	measured by number of lymph nodes retrieved and rate of optimal debulking.

Secondary

Measure	Time frame	Description
Operative time	1 day	—
Postoperative procedure related morbidity	1 month	Wound and chest complications
Blood loss	1 day	intraoperative
Hospital stay	1 month	—

Countries

Egypt

Contacts

Primary ContactIslam H Metwally, MSc, MRCS

drislamhany@mans.edu.eg01002985865

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026